FDA granted 510(k) clearance to include the use of 4 BD Bactec blood culture bottles for Microphage's KeyPath MRSA/MSSA Blood Culture Test-BT to identify Staphylococcus aureus and determine methicillin resistance (MRSA) or susceptibility (MSSA) in...

MicroPhage granted Cardinal Health exclusive U.S. and Canadian commercialization rights to KeyPath MRSA/MSSA Blood Culture Test and other undisclosed products in development to detect Staphylococcus aureus. Cardinal will fund development and commercialization of the products....

FDA granted 510(k) clearance to Microphage's KeyPath MRSA/MSSA Blood Culture Test to identify Staphylococcus aureus bacteria and determine methicillin resistance or susceptibility in suspected cases of bacteremia. The company expects to launch the product in...

Microphage Inc. , Longmont, Colo.   Business: Diagnostic   Hired: Don Mooney as CEO, formerly president and CEO of ProteoGenix Inc. ; he replaces interim CEO Drew Smith, who will remain CSO  ...

MicroPhage launched its Microphage MRSA/MSSA blood culture test outside the U.S. to identify Staphylococcus aureus bacteria and determine methicillin resistance or susceptibility in suspected cases of bacteremia. In March, MicroPhage submitted a 510(k) application to...

AspenBio Pharma Inc. (NASDAQ:APPY), Castle Rock, Colo.   Business: Veterinary, Diagnostic, Supply/Service   Hired: Steve Lundy as CEO and a director, formerly CEO of MicroPhage Inc.; he replaces interim CEO Daryl Faulkner, who will remain...

MicroPhage Inc. , Longmont, Colo.   Business: Diagnostic   Promoted: Alene Campbell to CEO from COO; she replaces Steve Lundy, who resigned  ...

MicroPhage submitted a 510(k) application to FDA for its Microphage MRSA/MSSA blood culture test to identify Staphylococcus aureus bacteria and determine methicillin resistance or susceptibility in suspected cases of bacteremia. The test, which uses MicroPhage's...

Microphage received CE Mark approval in the EU for its MRSA/MSSA Blood Culture Test to identify staphylococcus aureus bacteria and determine methicillin resistance (MRSA) or susceptibility (MSSA) in suspected cases of bacteremia. Microphage began a...

Microphage began a U.S. pivotal trial to evaluate its MRSA/MSSA blood culture test in about 700 patients. Microphage Inc. , Longmont, Colo.   Product: MRSA/MSSA blood culture test   Business: Diagnostic   Molecular target: NA  ...